Skip to main content
Premium Trial:

Request an Annual Quote

Biocept Selector Liquid Biopsy for Non-Small Cell Lung Cancer

Biocept announced it has launched a blood-based EGFR mutation test for non-small cell lung cancer patients based on its Selector technology platform. Screening circulating tumor cells and DNA, the assay targets a region of the gene that includes T790M, a biomarker that identifies therapy-resistant tumors. This test will be performed at the firm's CLIA-certified and CAP-accredited laboratory.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more